Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Risk of Acute Myeloid Leukemia in Adults with Primary Immune Thrombocytopenia Treated with Thrombopoietin Receptor Agonists: A French Nationwide Population-Based Study

Yoann Zadro, Margaux Lafaurie, Maryse Lapeyre-Mestre, Guillaume Moulis

Blood (2024) 144 (Supplement 1): 549.

https://doi.org/10.1182/blood-2024-200178

Published: 2024

Journal Articles

Adolescents and Young Adults with Secondary Chronic Immune Thrombocytopenia: A Switzerland/France Collaboration Project

Alexandra Schifferli, Nathalie Aladjidi, Guillaume Moulis, Marlies Gisin, Guy Leverger, Sebastien Heritier, Thierry Leblanc, Helder Fernandes, Mony Fahd, Thomas Kuehne

Blood (2024) 144 (Supplement 1): 548.

https://doi.org/10.1182/blood-2024-200034

Published: 2024

Journal Articles

Long term follow-up of the STOPAGO study

Blood blood.2024025707.

https://doi.org/10.1182/blood.2024025707

Published: 2024

Includes: Supplemental data

Journal Articles

Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study

Blood (2023) 142 (Supplement 1): 800.

https://doi.org/10.1182/blood-2023-178535

Published: 2023

Journal Articles

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Marion Larue, Guillaume Moulis, Manuela Rueter, Sylvain Audia, Louis Terriou, Jean-Francois Viallard, Brigitte Pan Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, Olivier Lambotte, Francois Lefrere, Stephane Cheze, Mikael Ebbo, Orianne Wagner-Ballon, Matthieu Mahevas, Bertrand Godeau, Marc Michel

Blood (2023) 142 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2023-181606

Published: 2023

Journal Articles

Evaluation of the Efficacy and Safety during Treatment with TPO-Ras in 40 SLE-ITP and APS-ITP Patients

Marques Cindy, Mickael Roussotte, Guillaume Moulis, Bernard Bonnotte, Jean-Francois Viallard, Nathalie Costedoat-Chalumeau, Alban Deroux, Pascal Sève, Bertrand Godeau, Matthieu Mahevas, Marc Michel

Blood (2023) 142 (Supplement 1): 1209.

https://doi.org/10.1182/blood-2023-187461

Published: 2023

Journal Articles

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Yoann Zadro, Margaux Lafaurie, Maryse Lapeyre-Mestre, Marc Michel, Guillaume Moulis

Blood (2023) 142 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2023-173444

Published: 2023

Journal Articles

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Natasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, Jean-François Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikaël Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2023) 142 (12): 1099–1101.

https://doi.org/10.1182/blood.2023020311

Published: 2023

Includes: Supplemental data

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Julien Maquet, Margaux Lafaurie, Marc Michel, Maryse Lapeyre-Mestre, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 8176–8177.

https://doi.org/10.1182/blood-2022-157730

Published: 2022

Journal Articles

Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Guy Leverger, Helder Fernandes, Thomas Kuehne

Blood (2022) 140 (Supplement 1): 5551–5552.

https://doi.org/10.1182/blood-2022-169194

Published: 2022

Journal Articles

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Guillaume Moulis, Manuela Rueter, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau

Blood (2022) 140 (Supplement 1): 5557–5558.

https://doi.org/10.1182/blood-2022-157723

Published: 2022

Journal Articles

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Natacha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 52–54.

https://doi.org/10.1182/blood-2022-157715

Published: 2022

Journal Articles

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2022) 139 (26): 3771–3777.

https://doi.org/10.1182/blood.2021014473

Published: 2022

Includes: Supplemental data

Journal Articles

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

Guillaume Moulis, Etienne Crickx, Laure Thomas, Nathalie Massy, Matthieu Mahévas, Marie-Blanche Valnet-Rabier, Marina Atzenhoffer, Marc Michel, Bertrand Godeau, Haleh Bagheri, Francesco Salvo

Blood (2022) 139 (16): 2561–2565.

https://doi.org/10.1182/blood.2022015470

Published: 2022

Includes: Supplemental data

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist

Blood (2021) 138 (Supplement 1): 849.

https://doi.org/10.1182/blood-2021-151615

Published: 2021

Journal Articles

A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia

Anais Roeser, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles, Hélène Labussière, Christelle Mausservey, Micheline Pha, Mathieu Puyade, Stephane Cheze, Nicolas Limal, Corinne Haioun, Marc Michel, Bertrand Godeau, Matthieu Mahevas

Blood (2021) 138 (Supplement 1): 3167.

https://doi.org/10.1182/blood-2021-153388

Published: 2021

Journal Articles

Association between Megakaryocyte Abnormalities on Bone Marrow Smear and Response to Thrombopoietin Receptor Agonists in Adult Patients with Primary Immune Thrombocytopenia

Ondine Walter, Agnès Ribes, Johanne Germain, Jean-Baptiste Rieu, Thibault Comont, Albertine Plat, Brigitte Rivière, Lauréline Deluche, Lucrecia Delarue, Isabelle Le Goff, Monique Greze, Béatrice Dubourdieu, Odile Beyne-Rauzy, Veronique De Mas, Guillaume Moulis

Blood (2021) 138 (Supplement 1): 3160.

https://doi.org/10.1182/blood-2021-151435

Published: 2021

Journal Articles

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2021) 138 (Supplement 1): 2048.

https://doi.org/10.1182/blood-2021-151307

Published: 2021

NARROW

Risk of Acute Myeloid Leukemia in Adults with Primary Immune Thrombocytopenia Treated with Thrombopoietin Receptor Agonists: A French Nationwide Population-Based Study

Adolescents and Young Adults with Secondary Chronic Immune Thrombocytopenia: A Switzerland/France Collaboration Project

Long term follow-up of the STOPAGO study

Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Evaluation of the Efficacy and Safety during Treatment with TPO-Ras in 40 SLE-ITP and APS-ITP Patients

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia

Association between Megakaryocyte Abnormalities on Bone Marrow Smear and Response to Thrombopoietin Receptor Agonists in Adult Patients with Primary Immune Thrombocytopenia

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only